DOI: 10.1055/s-00000025

Hormone and Metabolic Research

References

Lewiecki EM, Miller PD, McClung MR. et al.
Two-year treatment with denosumab (AMG 162) in a randomized phase 2 study of postmenopausal women with low BMD.

J Bone Miner Res 2007;
22: 1832-1841

Download Bibliographical Data

Access:
Access: